Co-Diagnostics (CODX) Competitors

Co-Diagnostics (NASDAQ:CODX) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Which has stronger valuation and earnings, CODX or SRTS?

Sensus Healthcare has higher revenue and earnings than Co-Diagnostics. Sensus Healthcare is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Co-Diagnostics	$3.91M	3.73	-$37.64M	-$1.15	-0.33
Sensus Healthcare	$41.81M	1.26	$6.65M	-$0.06	-53.58

Do analysts prefer CODX or SRTS?

Co-Diagnostics currently has a consensus target price of $5.50, suggesting a potential upside of 1,351.19%. Sensus Healthcare has a consensus target price of $8.00, suggesting a potential upside of 148.83%. Given Co-Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Co-Diagnostics is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Co-Diagnostics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sensus Healthcare	2 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.20

Is CODX or SRTS more profitable?

Sensus Healthcare has a net margin of -2.26% compared to Co-Diagnostics' net margin of -3,588.33%. Sensus Healthcare's return on equity of -1.58% beat Co-Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Co-Diagnostics	-3,588.33%	-69.49%	-60.49%
Sensus Healthcare	-2.26%	-1.58%	-1.41%

Which has more risk and volatility, CODX or SRTS?

Co-Diagnostics has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in CODX or SRTS?

15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 6.1% of Co-Diagnostics shares are owned by insiders. Comparatively, 8.9% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Does the media refer more to CODX or SRTS?

In the previous week, Sensus Healthcare had 1 more articles in the media than Co-Diagnostics. MarketBeat recorded 4 mentions for Sensus Healthcare and 3 mentions for Co-Diagnostics. Co-Diagnostics' average media sentiment score of 0.64 beat Sensus Healthcare's score of 0.25 indicating that Co-Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Co-Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sensus Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Sensus Healthcare beats Co-Diagnostics on 11 of the 17 factors compared between the two stocks.